Pfizer Inc (PFIZ34) — Cash Flow Reinvestment Rate
Pfizer Inc (PFIZ34) has a Cash Flow Reinvestment Rate of 0.63x as of March 2026, reinvesting R$1.64 Billion (capex R$436.00 Million plus investments R$1.20 Billion) from operating cash flow of R$2.62 Billion. Explore capital reinvestment ratio of Pfizer Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pfizer Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Pfizer Inc across 12 annual periods. Also explore Pfizer Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pfizer Inc (2014–2025)
Year-by-year capital reinvestment analysis for Pfizer Inc. For live market cap and broader valuation context, see Pfizer Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (BRL) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | R$4.36 Billion | R$11.71 Billion | R$2.63 Billion | ▼ -14.7% |
| 2024 | 0.44x | R$5.56 Billion | R$12.74 Billion | R$2.91 Billion | ▼ -82.2% |
| 2023 | 2.45x | R$29.56 Billion | R$12.04 Billion | R$3.86 Billion | ▲ +624.3% |
| 2022 | 0.34x | R$9.92 Billion | R$29.27 Billion | R$3.24 Billion | ▼ -50.3% |
| 2021 | 0.68x | R$22.23 Billion | R$32.58 Billion | R$2.71 Billion | ▲ +120.2% |
| 2020 | 0.31x | R$4.46 Billion | R$14.40 Billion | R$2.79 Billion | ▼ -67.2% |
| 2019 | 0.95x | R$11.90 Billion | R$12.59 Billion | R$2.59 Billion | ▲ +73.4% |
| 2018 | 0.55x | R$8.63 Billion | R$15.83 Billion | R$2.20 Billion | ▲ +107.7% |
| 2017 | 0.26x | R$4.41 Billion | R$16.80 Billion | R$2.22 Billion | ▼ -56.7% |
| 2016 | 0.61x | R$9.81 Billion | R$16.19 Billion | R$2.00 Billion | ▼ -44.5% |
| 2015 | 1.09x | R$16.04 Billion | R$14.69 Billion | R$1.40 Billion | ▲ +244.0% |
| 2014 | 0.32x | R$5.42 Billion | R$17.08 Billion | R$1.20 Billion | — |